Why Early Detection Matters
Lung cancer remains one of the leading causes of cancer-related deaths due to late diagnosis. Early detection significantly improves survival rates and treatment outcomes.
Advancing early detection of lung cancer through intelligent analysis and clinical insight.
Lung cancer remains one of the leading causes of cancer-related deaths due to late diagnosis. Early detection significantly improves survival rates and treatment outcomes.
AluScan™ is an advanced early-detection platform supporting clinicians in identifying lung cancer risk earlier using data-driven insights.
Detects subtle patterns beyond traditional screening methods.
Provides timely information for better clinical decisions.
Supports—not replaces—clinical expertise.
AluScan™ is designed for integration across clinical and research environments.
Integrated into diagnostic workflows in healthcare networks.
Supports clinical decision-making for cancer risk assessment.
Used in large-scale early detection initiatives.
Enables advanced clinical and translational research.
Join us in transforming lung cancer outcomes through earlier detection.
Contact Us